Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.
Int J Hematol
; 68(4): 445-8, 1998 Dec.
Article
in En
| MEDLINE
| ID: mdl-9885444
ABSTRACT
A 20-year-old male with ulcerative colitis complicated by mesalazine-associated severe aplastic anemia is described. The patient developed aplastic anemia four months after the start of mesalazine therapy. He was treated with antithymocyte globulin, cyclosporine, and granulocyte colony-stimulating factor (G-CSF) and responded well. Hematological complications of mesalazine are rare, but if bone marrow suppression is detected, immediate cessation of the drug and intensive immunosuppressive treatment with G-CSF should be considered.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anti-Inflammatory Agents, Non-Steroidal
/
Granulocyte Colony-Stimulating Factor
/
Cyclosporine
/
Mesalamine
/
Anemia, Aplastic
/
Antilymphocyte Serum
Type of study:
Risk_factors_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Int J Hematol
Journal subject:
HEMATOLOGIA
Year:
1998
Document type:
Article
Affiliation country:
Japan